Healthcare Global Enterprises Ltd.
Snapshot View

279.45 -4.25 ▼-1.5%

30 January 2023, 04:01:00 PM
Volume: 21,575

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.hcgoncology.com
Market Cap 3,866.09 Cr.
Enterprise Value(EV) 4,131.84 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -1.90 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 46.72 Trailing Twelve Months Ending 2022-09
Book Value / Share 63.34 Trailing Twelve Months Ending 2022-09
Price to Book Value 4.41 Calculated using Price: 279.45
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 13.91 Cr. 139,092,937 Shares
FaceValue 10
Company Profile
The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.50%
1 Week
-3.54%
1 Month
-2.83%
3 Month
-2.34%
6 Month
+3.77%
1 Year
+14.48%
2 Year
+84.52%
5 Year
-11.07%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -15.10 1.75 0.64 5.38 3.71 -6.48 -29.68 -43.32 5.16
Return on Capital Employed (%) -0.71 6.41 5.60 7.22 7.59 3.46 1.65 -9.66 15.17
Return on Assets (%) -5.91 0.64 0.25 2.06 1.29 -2.03 -6.51 -10.46 1.85

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 263 279 426 433 515 477 381 697 870 881
Non Curr. Liab. 257 279 306 354 483 557 1,232 822 860 867
Curr. Liab. 149 187 263 366 359 547 576 465 470 510
Minority Int. 18 25 33 57 64 46 39 17 13 9
Equity & Liab. 688 770 1,027 1,210 1,421 1,627 2,227 2,001 2,214 2,266
Non Curr. Assets 578 648 800 966 1,200 1,354 1,923 1,566 1,711 1,738
Curr. Assets 109 122 227 244 220 273 304 435 502 528
Misc. Exp. not W/O
Total Assets 688 770 1,027 1,210 1,421 1,627 2,227 2,001 2,214 2,266

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 450 519 584 700 829 976 1,092 1,009 1,395 1,551
Other Income 5 5 4 10 19 10 10 21 16 11
Total Income 455 524 588 710 848 986 1,103 1,030 1,410 1,562
Total Expenditure -413 -443 -499 -595 -716 -853 -923 -887 -1,160 -1,279
PBIDT 42 81 89 115 132 133 179 144 251 283
Interest -32 -34 -38 -23 -42 -70 -138 -119 -98 -99
Depreciation -36 -39 -44 -57 -71 -85 -148 -159 -158 -163
Taxation -5 2 2 -12 -10 3 -6 8 -49 -15
Exceptional Items -10 -5 -6 11 -93 95 -46
PAT -42 5 2 23 17 -31 -125 -221 39 -40
Minority Interest -2 -4 -4 -1 4 6 19 28 15 13
Share Associate 0
Other Related Items
Consolidated Net Profit -44 1 -1 22 21 -25 -107 -193 54 -26
Adjusted EPS -6 0 0 3 2 -3 -12 -15 4 -2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 29 50 60 73 91 98 99 130 121 220
Cash Fr. Inv. -100 -58 -80 -204 -210 -282 -238 -101 -171 125
Cash Fr. Finan. 66 23 22 216 89 161 84 -58 112 -155
Net Change -6 15 2 85 -29 -23 -56 -30 62 190
Cash & Cash Eqvt 11 25 25 80 51 27 -29 -59 3 193

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 66.87 70.71 68.41 68.40 71.44 71.43 71.42 71.39 71.38
Public 33.13 29.29 31.59 31.60 28.56 28.57 28.58 28.61 28.62
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 3.36 3.47 3.47 3.00 3.00 3.00 3.09 3.09

Announcements View Details >>

Wed, 25 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting And Earnings Call
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve Intimation of Meeting of Board of Directors and Earnings call to discuss the Unaudited Financial Results of HealthCare Global Enterprises Limited (the Company).
Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018.
Mon, 12 Dec 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of investor meeting

Technical Scans View Details >>

Mon, 30 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,051.70 +0.8%
Divi's Laboratories Ltd. 89,367.34 3,366.40 -0.6%
Cipla Ltd. 83,741.18 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. 52,291.51 1,545.05 +0.5%
Abbott India Ltd. 44,555.01 20,967.75 -1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 31.74 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,967.75 -1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-12 3.69 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,967.75 -1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,967.75 -1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,967.75 -1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,051.70 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,366.40 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,037.50 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,328.80 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,249.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.05 +0.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,967.75 -1.2%

FAQ's On Healthcare Global Enterprises Ltd.

What is HealthcareGlobal share price?

Can I buy HealthcareGlobal shares now?

What is the Market Cap of HealthcareGlobal?

What are the key metrics to analyse HealthcareGlobal?

What is the 52 Week High and Low of HealthcareGlobal?

What is the trend of HealthcareGlobal share price?